A tumor marker for pancreatic cancer helps healthcare professionals detect, diagnose, or treat it. However, a person can have high tumor marker levels without having cancer. Tumor markers are ...

Tumor markers can help doctors diagnose testicular cancer, determine effective treatment, and monitor how well that treatment is working. Doctors have been using tumor markers to help diagnose and ...

HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline Summary From the College of American Pathologists, American Society for Clinical Pathology, and American Society ...

Despite unknown clinical benefit, excessive or "extreme" testing to monitor disease is common among elderly women with metastatic breast cancer (MBC), new research shows. The testing that was analyzed ...

Over a 1-year period, the mean number of any individual test per patient was seven tests, and the maximum number was 35 tests; the mean number of total tests per patient was 12 tests, and the maximum ...

A personalized blood test known as a circulating tumor DNA (ctDNA) test—which detects tiny fragments of cancer DNA ...

Of all the types of breast cancer, triple negative breast cancer (TNBC) is the most aggressive and lacks specific therapies.

Recent research suggests that blood tests may show markers of oral cancer. But a blood test isn’t enough to confirm an oral cancer diagnosis. A biopsy is the only way to confirm it. Blood tests for ...

Researchers have modified a unique cancer-loving probiotic bacteria to release a marker that can be detected in the urine after it comes into contact with bowel cancer, even when it's in the early ...

Blood tests that promise to spot cancer before symptoms appear are racing toward clinics, pitched as a simple vial of blood that could replace invasive biopsies and catch tumors when they are still ...

Scientists have made progress on developing an experimental blood test that could detect many types of cancer in their early stages, and possibly even their locations in the body. Scientists have made ...

SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (BIAF) (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive, accurate tests for the detection of early-stage ...